Incidental mononuclear cell infiltrate in the uvea of cynomolgus monkeys

Dinesh P Sinha1, Mark E Cartwright, Robert C Johnson

  • 1Department of Drug Safety and Metabolism, Schering-Plough Research Institute, Lafayette, New Jersey 07848, USA. dineshwar.sinha@spcorp.com

Toxicologic Pathology
|March 16, 2006
PubMed

Insights

Mononuclear cell infiltrate (MCI) was found in the eyes of untreated monkeys during drug safety studies. This finding occurred in about 25% of studies, with higher incidence in specific eye tissues.

Area of Science:

  • Veterinary Ophthalmology
  • Toxicology
  • Primate Research

Background:

  • Mononuclear cell infiltrate (MCI) is a potential finding in ocular tissues.
  • Naïve, untreated cynomolgus monkeys serve as controls in drug safety evaluations.

Purpose of the Study:

  • To report the incidence and characteristics of MCI in the uvea of control cynomolgus monkeys.
  • To establish a baseline for ocular findings in preclinical drug safety studies.

Main Methods:

  • Histopathological examination of ocular tissues from control cynomolgus monkeys.
  • Analysis of incidence data for MCI in the uvea, choroid, and ciliary body.
  • Correlation of MCI findings with ophthalmoscopic examinations.

Main Results:

  • MCI was observed in approximately 25% of drug safety evaluation studies in naïve, untreated cynomolgus monkeys.
  • The overall incidence of MCI in the choroid and ciliary body was 29% in males and 25% in females.
  • When present, MCI incidence in the ciliary body or choroid reached up to 75% in affected studies.
  • No other ocular histopathological findings or clinical abnormalities were noted.

Conclusions:

  • MCI in the uvea is an incidental finding in a subset of control cynomolgus monkeys.
  • This finding does not appear to be associated with clinical health or other ocular pathologies.
  • Understanding the incidence of MCI is crucial for interpreting ocular findings in non-human primate drug safety studies.

Related Concept Videos